Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Forman

Showing results (721-730 of 1,052) with videos related to

Pageof 106
Sort By:
The Journal of Clinical Investigation|June 4, 2014
CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cellsAndreas Herrmann, Saul J Priceman, Piotr Swiderski, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 10, 2007
Health care utilization by adult long-term survivors of hematopoietic cell transplant: report from the Bone Marrow Transplant Survivor StudySadhna M Shankar, Andrea Carter, Can-Lan Sun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Importance of bone marrow cytogenetic evaluation before autologous bone marrow transplantation for Hodgkin's diseaseN J Chao, A P Nademanee, G D Long, et al.
Cancer Research|February 5, 2024
Immunometabolic Adaptation of CD19-Targeted CAR T Cells in the Central Nervous System Microenvironment of Patients Promotes Memory DevelopmentLior Goldberg, Eric R Haas, Ryan Urak, et al.
Cancer|August 31, 2019
Risk of venous thromboembolism in patients with non-Hodgkin lymphoma surviving blood or marrow transplantationRadhika Gangaraju, Yanjun Chen, Lindsey Hageman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 26, 2011
Host APCs augment in vivo expansion of donor natural regulatory T cells via B7H1/B7.1 in allogeneic recipientsTangsheng Yi, Xiaofan Li, Sheng Yao, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 1999
Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell developmentP V Sivakumar, A Gunturi, M Salcedo, et al.
Blood|October 28, 2004
Enhanced antilymphoma efficacy of CD19-redirected influenza MP1-specific CTLs by cotransfer of T cells modified to present influenza MP1Laurence J N Cooper, Zaid Al-Kadhimi, Lisa Marie Serrano, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 2, 2015
Influence of Absorption, Distribution, Metabolism, and Excretion Genomic Variants on Tacrolimus/Sirolimus Blood Levels and Graft-versus-Host Disease after Allogeneic Hematopoietic Cell TransplantationSamer K Khaled, Joycelynne M Palmer, Josef Herzog, et al.
Cytotherapy|May 16, 2006
Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphomaL J N Cooper, L Ausubel, M Gutierrez, et al.
Pageof 106

Showing results (721-730 of 1,052) with videos related to

Sort By:
Pageof 106
The Journal of Clinical Investigation|June 4, 2014
CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cellsAndreas Herrmann, Saul J Priceman, Piotr Swiderski, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 10, 2007
Health care utilization by adult long-term survivors of hematopoietic cell transplant: report from the Bone Marrow Transplant Survivor StudySadhna M Shankar, Andrea Carter, Can-Lan Sun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Importance of bone marrow cytogenetic evaluation before autologous bone marrow transplantation for Hodgkin's diseaseN J Chao, A P Nademanee, G D Long, et al.
Cancer Research|February 5, 2024
Immunometabolic Adaptation of CD19-Targeted CAR T Cells in the Central Nervous System Microenvironment of Patients Promotes Memory DevelopmentLior Goldberg, Eric R Haas, Ryan Urak, et al.
Cancer|August 31, 2019
Risk of venous thromboembolism in patients with non-Hodgkin lymphoma surviving blood or marrow transplantationRadhika Gangaraju, Yanjun Chen, Lindsey Hageman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 26, 2011
Host APCs augment in vivo expansion of donor natural regulatory T cells via B7H1/B7.1 in allogeneic recipientsTangsheng Yi, Xiaofan Li, Sheng Yao, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 1999
Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell developmentP V Sivakumar, A Gunturi, M Salcedo, et al.
Blood|October 28, 2004
Enhanced antilymphoma efficacy of CD19-redirected influenza MP1-specific CTLs by cotransfer of T cells modified to present influenza MP1Laurence J N Cooper, Zaid Al-Kadhimi, Lisa Marie Serrano, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 2, 2015
Influence of Absorption, Distribution, Metabolism, and Excretion Genomic Variants on Tacrolimus/Sirolimus Blood Levels and Graft-versus-Host Disease after Allogeneic Hematopoietic Cell TransplantationSamer K Khaled, Joycelynne M Palmer, Josef Herzog, et al.
Cytotherapy|May 16, 2006
Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphomaL J N Cooper, L Ausubel, M Gutierrez, et al.
Pageof 106